Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis

Abstract

TAVR could be a viable option for aortic valve replacement in cirrhosis patients.

Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis

“…This method uses lower priming volume, reduced foreign surface area, and interdisciplinary preoperative and postoperative treatment. Contrarily, reported mortality after TAVR in these patients is lower than that of SAVR, and ranges from 0 to 10% . Our study confirms these findings, and found similar lower in‐hospital mortality among patients with TAVR and SAVR.…”

“…Data on postoperative blood transfusion and PPM implantation specific to SAVR in cirrhotic patients are very limited . Due to widespread availability, expanded indications, and early favorable observational data on TAVR in the patients with cirrhosis, it is increasingly used to treat severe AS patients, in consideration of shorter length of stay and less procedural complications . Our data support findings from the previous small studies.…”

“…Another study evaluating outcomes of TAVR and SAVR in patients with cirrhosis only included samples from 2011 to 2012. They reported higher post‐procedure complications and longer length of stay in patients undergoing SAVR, compared to TAVR . The study was limited by small sample size and inclusion of patients from pre‐commercialization‐TAVR era.…”

“…Outcomes of TAVR, when compared to SAVR in patients with cirrhosis, are largely unknown. Only a few small studies have particularly evaluated TAVR outcomes in patients with cirrhosis .…”

Transcatheter Aortic Valve Replacement for ­Inoperable Severe Rheumatic Aortic Stenosis with Prior Mitral Valve Prosthesis

“…Hepatology evaluation suggested very high surgical risk due to chronic liver disease. Thus, she was referred for TAVR in the face of high surgical risk [7,8].…”